PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:04 AM ET

Sponsor Check › Person

CM
No photo found yet (own website and image search run after this page is viewed)

Christopher Marlett

Named as an officer, director or promoter on SEC Form D filings · CA, MA, WA, TX · Nov 13, 2014 → Jun 19, 2015

5deals (issuers)
$148.4Mreported sold
425investors
8Form D filings
2014–2015years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:32 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Christopher Marlett is listed as an executive officer and director on 8 SEC Form D filings by 5 issuers between Nov 2014 and Nov 2024: Pulse Biosciences, Inc. (Hayward, CA — other health care — 2014; $50M reported sold to 72 investors), Cue Biopharma, Inc. (Boston, MA — biotechnology — 2015–2016; $50M reported sold to 133 investors), MDB Capital Holdings, LLC (Dallas, TX — investing — 2022; $25.3M reported sold to 192 investors), theMaven, Inc. (New York, NY — other technology — 2017; $23.1M reported sold to 26 investors) and Invizyne Technologies Inc (Monrovia, CA — biotechnology — 2024; $12K reported sold to 2 investors).

What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $148.4M sold in total.

Listed alongside Anthony DiGiandomenico (6 shared filings), Amy Wang (5 shared filings), Gary Schuman (5 shared filings), Cameron Gray (4 shared filings), RODOLFO CHAPARRO (4 shared filings) and 19 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 11 bankruptcy cases matching the name listed in Key records below.

What this means 12 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 8 public filings for Christopher Marlett and found 7 differences, 1 worth asking the sponsor about: Amount sold went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Christopher Marlett has not run yet — it is joining a line of 5,655 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 closed (disposition not in docket feed)

Marlett v. Kimlor Mills, Inc. closed
District Court, D. Colorado · No. 1:91-cv-00082 · Filed Jan 16, 1991 · Closed May 20, 1991 · Nature of suit: 190 Contract: Other · Cause: 28:1441 Petition For Removal--Other Contract
Role of Marlett: Plaintiff · Outcome: Terminated 1991-05-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); surname only in the caption; court in CO (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:32 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Christopher Marlett..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

11 cases: 3 open, 8 closed (disposition not in docket feed)

Jose Enrique Ramirez and Marlett Ramirez open
United States Bankruptcy Court, C.D. California · No. 2:25-bk-16162 · Filed Jul 21, 2025
Role of Jose Enrique Ramirez and Marlett Ramirez: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); surname only in the caption; court in the person's filing state (CA)
MEGHJI v. William Marlett LLC open
United States Bankruptcy Court, S.D. New York · No. 24-02751 · Filed Jul 5, 2024
Role of William Marlett LLC: Defendant · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (william); court in the person's filing state (NY)
William Marlett Jones open
United States Bankruptcy Court, S.D. Indiana · No. 23-80361 · Filed Aug 31, 2023
Role of William Marlett Jones: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (william); court in IN (not a filing state)
Paul Marlett Johnson closed
United States Bankruptcy Court, W.D. Texas · No. 21-10171 · Filed Mar 12, 2021 · Closed Jun 18, 2021
Role of Paul Marlett Johnson: Debtor · Outcome: Case closed 2021-06-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (paul); court in the person's filing state (TX)
William Marlett Jones and Natasha Kay Jones closed
United States Bankruptcy Court, S.D. Indiana · No. 20-80042 · Filed Jan 31, 2020 · Closed Aug 1, 2023
Role of William Marlett Jones and Natasha Kay Jones: Debtor · Outcome: Case closed 2023-08-01 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (william); court in IN (not a filing state)
James Marlett Smith and Toni Rae Smith closed
United States Bankruptcy Court, S.D. Indiana · No. 49-JJG-7 · Filed Jul 6, 2017 · Closed Nov 7, 2019
Role of James Marlett Smith and Toni Rae Smith: Debtor · Outcome: Case closed 2019-11-07 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (james); court in IN (not a filing state)
Jose Enrique Ramirez and Marlett Ramirez closed
United States Bankruptcy Court, C.D. California · No. 2:12-bk-27133 · Filed May 15, 2012 · Closed Jan 24, 2013
Role of Jose Enrique Ramirez and Marlett Ramirez: Debtor · Outcome: Case closed 2013-01-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); surname only in the caption; court in the person's filing state (CA)
Ronald Lee Smith and ShaRona Marlett Smith closed
United States Bankruptcy Court, S.D. Ohio · No. 2:06-bk-51542 · Filed Apr 8, 2006 · Closed Aug 2, 2006
Role of Ronald Lee Smith and ShaRona Marlett Smith: Debtor · Outcome: Case closed 2006-08-02 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (sharona); court in OH (not a filing state)
Sonya Marlett Smith closed
United States Bankruptcy Court, N.D. Ohio · No. 03-26707 · Filed Dec 19, 2003 · Closed Mar 15, 2004
Role of Sonya Marlett Smith: Debtor · Outcome: Case closed 2004-03-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (sonya); court in OH (not a filing state)
Arnold v. Marlett Holding Corp. closed
United States Bankruptcy Court, W.D. New York · No. 2-02-02084 · Filed Mar 8, 2002 · Closed Nov 22, 2002
Role of Marlett Holding Corp.: Defendant · Outcome: Case closed 2002-11-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); surname only in the caption; court in the person's filing state (NY)
Joseph Marlett Pope closed
United States Bankruptcy Court, M.D. North Carolina · No. 01-12835 · Filed Oct 4, 2001 · Closed Jan 22, 2002
Role of Joseph Marlett Pope: Debtor · Outcome: Case closed 2002-01-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 18 federal dockets); different first name (joseph); court in NC (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:32 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

7 differences found between the filings for Christopher Marlett — 1 worth asking about (compared 8 filings on Oct 24, 2026)

Worth asking · Dec 22, 2016 – Dec 30, 2016

Amount sold went down between filings — Cue Biopharma, Inc.

The Dec 22, 2016 filing says $20,000,000 sold; the Dec 30, 2016 Form D/A says $16,414,900 sold — $3,585,100 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Sources
Note · Dec 22, 2016 – Dec 30, 2016

Offering amount lowered between filings — Cue Biopharma, Inc.

The Dec 22, 2016 filing says $20,000,000 offered; the Dec 30, 2016 Form D/A says $16,414,900.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Mar 9, 2017 – Mar 17, 2017

No amendment in the last 12 months on an offering that may still be open — theMaven, Inc. (latest filing Mar 17, 2017)

The latest filing for this offering is dated Mar 17, 2017 (first sale Mar 9, 2017). It reports $500,000 sold of $5,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jun 15, 2015 – Jun 19, 2015

No amendment in the last 12 months on an offering that may still be open — Cue Biopharma, Inc. (latest filing Jun 19, 2015)

The latest filing for this offering is dated Jun 19, 2015 (first sale Jun 15, 2015). It reports $0 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Nov 6, 2014 – Nov 13, 2014

No amendment in the last 12 months on an offering that may still be open — Pulse Biosciences, Inc. (latest filing Nov 13, 2014)

The latest filing for this offering is dated Nov 13, 2014 (first sale Nov 6, 2014). It reports $7,999,997 sold of $8,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jun 19, 2015 – Dec 22, 2016

Address moved from Santa Monica, CA to Cambridge, MA — Cue Biopharma, Inc.

The people listed on the Jun 19, 2015 filing give Santa Monica, CA; on the Dec 22, 2016 filing they give Cambridge, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Nov 13, 2014 – Nov 19, 2024

Christopher Marlett is listed with 4 different address states: CA, MA, WA, TX

CA on 3 filings (Nov 13, 2014 to Jun 19, 2015); MA on 2 filings (Dec 22, 2016 to Dec 30, 2016); WA on 1 filing (Mar 17, 2017); TX on 2 filings (Jun 23, 2022 to Nov 19, 2024).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 7 offerings report sales commissions totalling $3,555,514; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Nov 19, 2024 D
Invizyne Technologies Inc
File 021-529770
$0$0$0Public Ventures LLC d/b/a MDB Capital BrokerCheck CRD 42677 ↗EDGAR ↗
Jun 23, 2022 D
MDB Capital Holdings, LLC
File 021-449985
$184,770$0$0Cambria Capital, LLC BrokerCheck CRD 133760 ↗
Paulson Investment Company LLC BrokerCheck CRD 42677 ↗
EDGAR ↗
Mar 17, 2017 D
theMaven, Inc.
File 021-282799
$250,000 (est.)$0$0
Proceeds will be used for general working capital purposes
MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
Dec 30, 2016 D/A
Cue Biopharma, Inc.
File 021-276931
$1,320,745$0$0MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
Jun 19, 2015 D
Cue Biopharma, Inc.
File 021-242130
$1,000,000 (est.)$0$0MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
Jun 19, 2015 D
Cue Biopharma, Inc.
File 021-242131
$0$0$0None listed on this filingEDGAR ↗
Nov 13, 2014 D
Pulse Biosciences, Inc.
File 021-228251
$799,999$0$0MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 5

Every issuer that named Christopher Marlett on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Invizyne Technologies Inc

Monrovia, CA · Nov 19, 2024
  • Nov 19, 2024 · D · $11,718 sold of $11,718 · 2 investors · min. $1,000 · role: Director EDGAR ↗

Raised $12K from 2 investors (100% of the $12K target) as of the latest filing. Christopher is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Investing

MDB Capital Holdings, LLC

Dallas, TX · Jun 23, 2022
  • Jun 23, 2022 · D · $25,289,676 sold of $25,289,676 · 192 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $25.3M from 192 investors (100% of the $25.3M target) as of the latest filing. Christopher is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Investing / 506(b) (2,521 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Technology

theMaven, Inc.

New York, NY · Mar 17, 2017
  • Mar 17, 2017 · D · $500,000 sold of $5,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $23.1M from 26 investors (100% of the $5M target) as of the latest filing. Christopher is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Cue Biopharma, Inc.

Boston, MA · Jun 19, 2015 → Dec 30, 2016 · 4 filings
  • Dec 30, 2016 · D/A · $16,414,900 sold of $16,414,900 · 133 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2016 · D · $20,000,000 sold of $20,000,000 · 133 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2015 · D · $0 sold of $1,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2015 · D · $10,000,000 sold of $10,000,000 · 121 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 133 investors (100% of the $16.4M target) as of the latest filing. Christopher is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Pulse Biosciences, Inc.

Hayward, CA · Nov 13, 2014
  • Nov 13, 2014 · D · $7,999,997 sold of $8,000,000 · 72 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 72 investors (100% of the $8M target) as of the latest filing. Christopher is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Christopher 24

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony DiGiandomenico

Director, Executive Officer · 6 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Wang

Executive Officer, Director · 5 shared filings (2 issuers) · also on 3 other issuers

Amy Wang is on 5 issuers in total — a repeat sponsor. Their page lists every one.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Schuman

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Cameron Gray

Executive Officer, Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

RODOLFO CHAPARRO

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald D. Seidel, III

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel R. Passeri

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Levande

Executive Officer, Director · 2 shared filings (2 issuers)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Almo

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

STEVEN MCKNIGHT

Director · 2 shared filings (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

PK
No photo found yet (own website and image search run after this page is viewed)
Person

PETER KIENER

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

BARRY SIMON

Director · 2 shared filings (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James Heckman

Executive Officer, Director · 1 shared filing (1 issuer) · also on 5 other issuers

James Heckman is on 6 issuers in total — a repeat sponsor. Their page lists every one.

PM
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Mills

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Sornsin

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Ross Levinson

Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

BJ
No photo found yet (own website and image search run after this page is viewed)
Person

Benjamin Joldersma

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Bowie

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Heltzen

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Mo Hayat

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

George Brandon

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Mohammad Hayat

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

James Lalonde

Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

LB
No photo found yet (own website and image search run after this page is viewed)
Person

Lon Bell

Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Marlett. Their page shows their other deals.

The team behind the deals

Registrations and other filings

Adviser registration (Form ADV)

None of the 5 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Christopher Marlett by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 5 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Christopher Marlett is listed on: none on file. No website or social profile named in MDB Capital Holdings, LLC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #152,693 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Dallas, TX). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Christopher Marlett appears on a new Form D, or when a court case or SEC action is matched to them. See plans →